DSIP is not FDA-approved for any therapeutic indication
It's the bedrock of reliable data
Also Read: Low vitamin D increases diabetic retinopathy "Unfortunately, in our study, there was no available semaglutide data," the researchers note, "(and) this database will not be ideal for future analysis because adverse event reporting is likely to be confounded by greater attention to the potential issue with semaglutide." "Our analysis of the FAERS database indicates that there is no signal for the association between GLP-1RA and DR, which is consistent with the Exenatide Study of Cardiovascular Event Lowering (EXSCEL) and Liraglutide Effect and Action in Diabetes
doi: 10.1007/s11892-018-1011-7 61 VitaleMHaxhiJCirritoTPuglieseG
"If you want to lose weight, start by speaking to a primary care physician," Dr
The most significant factor is rapid weight loss , which is a well-established trigger for telogen effluvium